Barasch Richard A.'s Insider Trades & SAST Disclosures
Barasch Richard A.'s most recent trade in Oncology Institute Inc (The) was a trade of 80,000 Common stock done . Disclosure was reported to the exchange on Nov. 22, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barasch Richard A..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 80,000 | 417,193 | - | 0 | Common stock | |
| AdaptHealth Corp | Richard A. Barasch | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. | 18 Jun 2024 | 3,559 | 438,355 (1%) | 0% | 9.9 | 35,199 | Common Stock |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 07 May 2024 | 8,547 | 441,914 (1%) | 0% | 9.9 | 84,188 | Common Stock |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 8,829 | 450,461 (1%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 21,206 | 451,632 (1%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.23 per share. | 29 Feb 2024 | 8,984 | 430,426 (1%) | 0% | 10.2 | 91,906 | Common Stock |
| AdaptHealth Corp | Richard Barasch A. | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 22,291 | 448,636 (1%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.26 per share. | 29 Dec 2023 | 9,226 | 439,410 (1%) | 0% | 7.3 | 66,981 | Common Stock |
| Oncology Institute Inc (The) | Barasch Richard A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 80,000 | 337,193 | - | 0 | Common stock | |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 17,143 | 396,664 (0%) | 0% | 0 | Common Stock | |
| AdaptHealth Corp | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 25,614 | 379,521 (0%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 257,193 | - | 0.6 | 5,500 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 247,193 | - | 0.6 | 5,500 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 217,193 | - | 0.6 | 5,500 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 9,948 | 227,393 | - | 0.5 | 5,471 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 7,654 | 235,047 | - | 0.6 | 4,210 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 2,146 | 237,193 | - | 0.5 | 1,176 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 200 | 217,445 | - | 0.6 | 110 | Common stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 17 Mar 2023 | 52 | 217,245 | - | 0.6 | 29 | Common stock |
| AdaptHealth Corp | Richard A. Barasch | Director, Interim CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 10,000 | 343,907 (0%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 164,727 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 548,503 | 548,503 | - | - | Private Placement Warrants | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 73,024 | 73,024 | - | - | Earnout rights (Private placement warrants) | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 6,204 | 6,204 | - | - | Series A Common Stock Equivalent Convertible Preferred Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 1,595 | 1,595 | - | - | Series A Common Stock Equivalent Convertible Preferred Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 894 | 894 | - | - | Earnout rights (Series A Common Stock Equiv Conv Preferred) | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 230 | 230 | - | - | Earnout rights (Series A Common Stock Equiv Conv Preferred) | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 8 | 8 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 1 | 142,019 | - | 0 | Common stock | |
| AdaptHealth Corp | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 14,970 | 353,907 (0%) | 0% | 0 | Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 45,905 | 142,018 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.81 per share. | 24 Nov 2021 | 2,000 | 93,113 | - | 6.8 | 13,618 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.86 per share. | 24 Nov 2021 | 1,800 | 94,913 | - | 6.9 | 12,344 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 7.20 per share. | 24 Nov 2021 | 1,200 | 96,113 | - | 7.2 | 8,643 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 23 Nov 2021 | 4,500 | 91,113 | - | 6.3 | 28,566 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.27 per share. | 23 Nov 2021 | 500 | 86,613 | - | 6.3 | 3,133 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 10.12 per share. | 16 Nov 2021 | 1,000 | 86,113 | - | 10.1 | 10,115 | Common Stock |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 100,000 | 0 | - | - | Class B Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 100,000 | 100,000 | - | - | Common Stock | |
| Oncology Institute Inc (The) | Richard A. Barasch | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Nov 2021 | 14,887 | 85,113 | - | - | Common Stock | |
| AdaptHealth Corp | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2021 | 9,017 | 338,937 (0%) | 0% | 0 | Common Stock | |
| CareMax Inc - Ordinary Sha... | Richard A. Barasch | Director | 08 Jun 2021 | 50,000 | 0 | - | - | Class B Common Stock | ||
| CareMax Inc - Ordinary Sha... | Richard A. Barasch | Director | 08 Jun 2021 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| CareMax Inc - Ordinary Sha... | Richard A. Barasch | Director | 08 Jun 2021 | 50,000 | 0 | - | - | Class B Common Stock | ||
| CareMax Inc - Ordinary Sha... | Richard A. Barasch | Director | 08 Jun 2021 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| AdaptHealth Corp | Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2020 | 9,017 | 344,920 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges